Pharma Pricing & Contracting Innovation Conference

Join a cohort of peers and industry executives to discuss innovation in pricing, access, and contracting at PCIC 2026, hosted by EVERSANA.

Save the Date for PCIC 2027

March 16-17, 2027

Registration opening soon

Learn More

Overview

Join a cohort of peers and industry executives at the 2026
Pharma Pricing & Contracting Innovation Conference, hosted by EVERSANA

Be inspired by thought-leading pharma speakers zooming in on key insights & best practices to manage pricing globally
Get educated on the latest life sciences commercial innovation trends
Discover case studies and innovative solution showcases
Network with your peers and industry experts
Experience our latest products, and innovations aimed to improve decision making for pricing & access professionals

Registration

Conference registration includes

Access to Workshop and Conference
Breakfast, Lunch, and drinks/snacks each day
Exclusive networking dinner
Copies of all presentations and more!
For discounted group rates, please contact the NAVLIN team. Complimentary access is available for payers, government agencies, and academics wishing to attend the conference.

Agenda

Time	Track 1: U.S.	Track 2: Global
09:00	Coffee & Networking
09:15	Overview of EVERSANA's New Commercialization Models and How Value, Pricing & Contracting work with New Commercialization Speaker Alan Crowther and Jim Burke Session Details Overview of EVERSANA's Value, Pricing, and Contracting services within the broader EVERSANA Commercial Vision, highlighting how these offerings are revolutionizing U.S. and global commercialization and their impact on Value, Pricing, and Contracting strategies.
10:00	Workshop: NAVLIN Revenue Management Overview Speaker Jim Burke, Mike Kurland, and Maria Eckley Session Details Overview of the NAVLIN Revenue Management platform and roadmap for 2025, including case studies on maximizing the platform's value, coverage of direction, key enhancements, and roadmap items in 2025.	Workshop: Global Launch Primer for U.S. Speaker Alan Crowther and Chad Gibson Session Details Understanding ex-U.S. pricing and market access for professionals with a primarily U.S.-focused background. This session explores key differences, major policy trends and shifts, and strategies for evaluating product potential in a global launch.
12:00	🍽️ Lunch
01:00	Moderator Welcome: Nina Mosher
01:05	Keynote - US Regulatory Landscape - IRA and Beyond Speaker Jim Burke, Chad Gibson, and Mike Kurland Session Details A comprehensive review of what the current landscape and likely policy changes will look like 90 days into the Trump administration, including the future of the IRA, ACA, 340B, and more.
01:50	Modern Market Access: Holistic Strategies vs. Traditional Financial Agreements Speaker Jay Seemann, BeiGene Session Details Explore how a flexible and holistic approach to market access can help drive success in an increasingly complex and difficult access landscape in the U.S.	NAVLIN Data: A Tool for US and Global Pricing Insights Speaker Andrew Hanhauser Session Details NAVLIN Data is the gold standard for global drug pricing teams—now see how it elevates U.S. drug price and access analysis. Explore new features designed for U.S. pricing insights, access trends, and generic drug price evaluation.
02:30	Dispute Resolution Across 340b, Commercial and Medicaid Speaker Jim Burke and Kalderos Session Details From initial contract negotiations through invoice processing, explore some of the key steps you can take to ensure all discounts are appropriate and not paid units acquired under the 340b program.	Gross-to-Net Success Speaker Alan Crowther and Kathleen Kulp Session Details How to plan, forecast, and realize net revenue across all aspects from contracting to co-pay.
03:00	Driving Patient Access: Analyzing Copays and Patient Access Speaker Chad Gibson and Brian Cotten Session Details Take a look at how analytics are driving change in copay use and how the regulatory framework may aid or challenge firms efforts to assist patients.	US & Global Gene Therapy Price and Access Speaker Swami Subramanian, Regeneron Session Details Exploring global gene therapy pricing and access and thinking about what it means for gene therapies in the pipeline.
03:30	☕️ Break
03:45	Using Analytics Backed Models and Presenting to Pricing Committees Speaker Mike Kurland and Kathleen Kulp Session Details Explore how data driven analytics-backed models enhance pricing strategies and demonstrate techniques for presenting insights effectively to pricing committees using backed evidence and scenario analysis.	Predicting US and Global Orphan Drug Pricing Speaker Chad Gibson and Paul Voss, Rezolute Session Details Leveraging AI and modeling to accelerate the assessment of orphan drug pricing and value, with insights into future trends in orphan drug pricing and access.
04:20	Insights into Managing Customer Eligiblity Networks Speaker Maria Eckley Session Details Roster data is often messy and difficult to align with company platforms - learn how to manage this process efficiently and gain more insights into your customer network structures.	Ask NAVLIN: Hands on Use of GenAI in Pricing & Contracting Speaker Andrew Hanhauser Session Details Explore how NAVLIN is advancing Pricing, Access and Contracting with GenAI to accelerate team productivity and generate faster data insights.
05:00	Plenary - Direct to Patient and it's Impact on Pricing & Market Access Speaker Chad Gibson Session Details Chad Gibson will present on AI Direct-to-Patient and other future trends that will impact pricing.
05:30	Closing Remarks
7:00	🍸 Cocktails & 🍽️ Dinner Session Details An Evening with the Innovators at The Library St. Petersburg.

Time	Track 1: U.S.	Track 2: Global
08:00	🍽️ Breakfast
08:25	Moderator Welcome: Nina Mosher
08:30	Looking at IRA CMS Negotiations from the Driver’s Seat Speaker Omar Ali, Verpora and Ross Margulies, Manatt, Phelps & Phillips LLP, with facilitator Nick Merryfield, Verpora Session Details Insights gained from the initial round of IRA negotiations by those who prepared and participated: an evaluation of effective and ineffective preparation methods, and anticipations for potential differences in future rounds.
09:30	From Coverage Gap to MDP Speaker Megan Seyboth Session Details Impacts on manufacturer liabilities in the Part D space as the program transitions between the old and new structures	Driving a Successful Price & Market Access for a Global Launch Speaker Alan Crowther Session Details How to plan price & market access for a global launch - with a focus on critical considerations for smaller biopharma companies preparing for their first international release.
10:05	Beyond Outsourcing - Strategic Revenue Management Partnerships Speaker Jim Burke and client panel Session Details Beyond just providing operational services, the RMS team is dedicated to ensuring our clients' success through valuable insights and consulting. Listen to your colleagues share how they've maximized their partnership with us.	US and Global Indication Sequence Planning Speaker Chad Gibson Session Details How changes in IRA and global policies influence thinking about indication sequencing and strategies for planning.
10:40	☕️ Break
11:00	Leveraging Contract Analytics in PBM Negotiations Speaker Brian Cotten, Chad Gibson Session Details An in-depth examination of analytical tools that can effectively facilitate PBM negotiations and how to leverage them to improve your success in contract negotiations.	Next Generation of NAVLIN Global Price & Market Access Speaker Gary Watson Session Details Overview of the roadmap and next-generation enhancements for NAVLIN's Global Pricing and Market Access software.
11:45	Payer Marketing Case Study Speaker Patrick Beers and Stephanie Feher, Novo Nordisk Session Details Gain insights from experts on effective strategies and execution in U.S. payer marketing, featuring an in-depth walkthrough of a successful case study.	Implementing NAVLIN US and Globally Speaker Gary Watson and client panel Session Details Strategies for implementing NAVLIN as a unified platform for pricing, market access, and contracting across the U.S. and global markets.
12:30	🍽️ Lunch
01:30	What's in an Analogue? Innovative Case Study Speaker Nick Milazzo Session Details Approaches to leveraging analogues in market access, pricing, and contracting, with case studies showcasing effective and innovative analogue analyses.	Preparing for EU JCA Speaker Chad Gibson and Alan Crowther Session Details EU JCA is here for oncology products and coming in 2028 for orphan and rare disease. This covers the need to prepare for this now, as soon as the end of Phase II, even when commercial is still focused on US launch.
02:15	Navigating Launch - A State Drug Price Transparency Perspective Speaker Mike Kurland and Brian Ushler Session Details Navigating State Drug Price Transparency (SDPT) regulations is a critical aspect of a new product launch. This session will provide a detailed exploration of these requirements, spanning from pre-PDUFA stages to post-launch compliance.	Digitizing the Tracking of Price & Access in Global Launches Speaker Gustav Ando and Alan Crowther Session Details Examining metrics and strategies for tracking and measuring the success of global launches, with insights tailored for both large and small biopharma companies. Discover how to transition from traditional tools like PowerPoint and Excel to advanced digital models for enhanced effectiveness.
03:00	☕️ Break
03:20	Navlin RMS Client Portal Speaker Jim Burke Session Details Engage in an interactive discussion on maximizing insights and leveraging the latest features of the NAVLIN Revenue Management platform.	Oncology Pricing & Contracting Trends Speaker Chad Gibson Session Details An overview of U.S. and global pricing and contracting trends, with projections on payer expectations over the next five years.
04:00	The Future of AI in Pricing & Market Access Speaker Alan Crowther Session Details Alan Crowther will present a US and Global perspective on how AI is - and isn't - changing Pricing and Market Access for the biopharma industry.
04:30	Closing Remarks & Customer Award Ceremony Session Details Conference closing remarks and customer award ceremony.
05:30	End of Conference

Venue and Accommodations

Westin Tampa Downtown Waterside Ideally located on Harbour Island, just steps from the Tampa Riverwalk and within walking distance of the city's top restaurants, waterfront attractions, and vibrant downtown entertainment.

Contact Us

Feel free to contact us via live chat or email or schedule a meeting to connect with our team about the conference! We are excited to see you in Basel!

Live Chat Schedule Meeting info@navlin.com